Hypertension Clinical Trials

Find Hypertension Clinical Trials Near You

Development of a Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy (Moms@Home)

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• Age 18-50

• English or Spanish speaking

• A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age)

• Singleton or multiple gestation pregnancy,

• A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts

• Willing to share home blood pressure monitoring data

• Comfortable with the use of smartphones and mobile apps

Locations
United States
Massachusetts
UMass Memorial Medical Center - Memorial Campus
RECRUITING
Worcester
Contact Information
Primary
Lara Kovell, MD,MSc
lara.kovell2@umassmed.edu
(508) 856-2772
Backup
Abigail Arthur, MBChB, MPH
abigail.arthur@umassmed.edu
(508) 856-4394
Time Frame
Start Date: 2025-05-16
Estimated Completion Date: 2027-11-16
Participants
Target number of participants: 100
Treatments
Experimental: Moms@Home arm
Participants randomized to Moms@Home will receive the Moms@Home app (± Samsung smartphone) to self-report data including home blood pressure monitoring values from a digital blood pressure monitor and physical activity data from a FitBit activity tracker.
Active_comparator: Enhanced Standard Care arm
Participants randomized to Enhanced Standard Care (ESC) will receive a paper diary to self-report data including measurements from a digital blood pressure monitor.
Related Therapeutic Areas
Sponsors
Leads: University of Massachusetts, Worcester
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov